Clinical Considerations for Monkeypox in Children and
Adolescents
|
|
The Centers for Disease
Control and Prevention (CDC) has released considerations for the
clinical management of monkeypox in children and adolescents younger
than 18 years old. These considerations are intended to help U.S.
clinicians and health systems develop a plan for managing children and
adolescents with exposure to monkeypox, suspected monkeypox, or
confirmed monkeypox.
|
|
|
- Young
children, children with eczema and other skin conditions, and
children with immunocompromising conditions may be at increased risk
of severe disease when they contract monkeypox.
- Treatment
should be considered on a case-by-case basis for children and
adolescents with suspected or confirmed monkeypox who are at risk
of severe disease or who develop complications of monkeypox.
Tecovirimat is the first-line medication to treat monkeypox,
including in children and adolescents.
- Children
and adolescents with exposure to people with suspected or confirmed
monkeypox may be eligible for post-exposure prophylaxis (PEP) with
vaccination, immune globulin, or antiviral medication.
|
|
The Emergency Risk Communication
Branch in the Division of Emergency Operations, Center for Preparedness
and Response is responsible for the management of all COCA
Products.
For information about this update
or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov
COCA RSS Feed—subscribe to be
notified of conference calls, updates, and CDC guidance for health
providers
Health Alert
Network—CDC's
primary method of sharing cleared information about urgent public health
incidents with public information officers; federal, state, territorial,
and local public health practitioners; clinicians; and public health
laboratories
|
|
|
|
CDC
and HHS logos are the exclusive property of the Department of Health and
Human Services and may not be used for any purpose without prior express
written permission. Use of trade names and commercial sources is for
identification only and does not imply endorsement by the U.S. Department
of Health and Human Services.
|
|
Links to non-federal
organizations are provided solely as a service to our users. Links do not
constitute an endorsement of any organization by CDC or the federal
government, and none should be inferred. CDC is not responsible for the
content of the individual organizations.
|
|
Centers for Disease Control
and Prevention
1600 Clifton Rd
Atlanta, GA 30329 1-800-CDC-INFO
(800-232-4636) TTY: 888-232-6348
Questions or
Problems | Unsubscribe
|
|
|
|
|
